NVS Message Board Post 11060624 | Novartis AG
home / stock / nvs / nvs message board
kenmil
(investorshangout)
Posted on: Jun/10/2018 16:08:59
Source: investorshangout
https://investorshangout.com/post/view?id=5081484
Debunker1: Entresto is nothing more than an attempt by Novartis to extend the patent life of Diovan (Valsartan)
News, Short Squeeze, Breakout and More Instantly...
Novartis AG Company Name:
NVS Stock Symbol:
Market:
-
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company's IgA nephropathy (IgAN) portfolio PR Newswire In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demons...
-
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo PR Newswire Secondary endpoint data for estimated glomerular filtration rate (eGF...